Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
30
days
Rethinking gene therapy for X-linked retinoschisis: from vitreous to subretinal space
Authors
Robyn V. Jamieson; John R. Grigg; Samantha L. GinnShow moreShow less
Affiliations
1. Eye Genetics Research Unit, Children’s Medical Research Institute, Sydney Children’s Hospitals Network, Save Sight Institute, The University of Sydney, Sydney, Australia; 2. Department of Clinical Genetics, Western Sydney Genetics Program, Sydney Children’s Hospitals Network, Sydney, Australia; 3. Specialty of Genomic Medicine, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 4. Sydney Eye Hospital, Sydney, Australia; 5. Specialty of Ophthalmology, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 6. Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Sydney, AustraliaShow moreShow less
199
days
Deep single-cell immune- and signaling profiles predict therapy response in chronic myeloid leukemia within hours
Authors
Stein-Erik Gullaksen; Mathias Brevik; Erin Craig; Monica Hellesøy; Øystein Sefland; Ulla Olsson-Strömberg; Jesper Stentoft; Johan Richter; Tobias Gedde-Dahl; Robert Tibshirani; Sylvia K. Plevritis; Dominik Wolf; Satu Mustjoki; Henrik Hjorth-Hansen; Bjørn Tore GjertsenShow moreShow less
Affiliations
1. Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway; 2. K.G. Jebsen Centre for Myeloid Blood Cancer CMYC, Department of Clinical Science, University of Bergen, Bergen, Norway; 3. Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway; 4. Department of Chemistry, University of Bergen, Bergen, Norway; 5. Department of Biostatistics, University of Michigan, Ann Arbor, USA; 6. Department of Research and Innovation, Fonna Hospital Trust, Haugesund, Norway; 7. Department of Medical Science and Division of Hematology, Uppsala University Hospital, Uppsala, Sweden; 8. Aarhus University Hospital, Aarhus, Denmark; 9. Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; 10. Department of Hematology, Oslo University Hospital and Institute of clinical medicine, University of Oslo, Oslo, Norway; 11. Department of Biomedical Data Science, Stanford University, Stanford, CA, USA and Department of Radiology, Stanford University, Stanford, USA; 12. Department of Statistics, Stanford University, Stanford, USA; 13. Department of Internal Medicine V, Haematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Austrian Comprehensive Cancer Network (ACCN), Medical University of Innsbruck (MUI), Innsbruck, Austria; 14. Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland; 15. Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; 16. ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; 17. University IKOM, Norwegian University of Science and Technology, Trondheim, NorwayShow moreShow less
38
days
Intrinsic cardiac neural circuits: supporting basal cardiac function and stress resilience
Authors
Yeojeong Jeong; Sung-Hwan Moon; Taeho KwonShow moreShow less
Affiliations
1. Quantum AI Bio Research Laboratory (KJQI-JQL), Futuristic Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; 2. Department of Animal Science and Technology, Chung-Ang University, Anseong, Republic of Korea; 3. Advanced Bioconvergence Department, KRIBB School, Korea National University of Science and Technology (UST), Daejeon, Republic of KoreaShow moreShow less
185
days
Engineering signal transduction for closed-loop gene and cell therapies
Authors
Haifeng Ye; Martin FusseneggerShow moreShow less
Affiliations
1. School of Life Sciences, East China Normal University, Shanghai, China; 2. Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland; 3. Faculty of Science, University of Basel, Basel, SwitzerlandShow moreShow less
248
days
Deinococcus wulumuqiensis -derived nanovesicles promote integrated tissue regeneration
Authors
Minghui Liu; Shuxiang Wang; Yin Zhou; He Huang; Ling JiangShow moreShow less
Affiliations
1. State Key Laboratory of Materials-Oriented Chemical Engineering, Jiangsu Provincial University Key Laboratory of Green Biomanufacturing for Pharmaceuticals, Nanjing Tech University, Nanjing, China; 2. School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, ChinaShow moreShow less
27
days
HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease
Authors
Jochen MattnerShow moreShow less
Affiliations
1. Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany; 2. FAU Profilzentrum Immunmedizin (FAU I-MED), FAU Erlangen-Nürnberg, Erlangen, GermanyShow moreShow less
FAQ
How long does Signal Transduction and Targeted Therapy take to review a manuscript?
As of 2026-11-18, CrushSCI has 25 complete review records for Signal Transduction and Targeted Therapy. The fastest paper went from submission to acceptance in 8 days (Precision tuning of STING signaling: a mutational blueprint, received 2026-07-14, accepted 2026-07-22); the slowest took 438 days. The average is 196.7 days and the median is 244 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
